Jpmorgan Chase & CO Medtronic PLC Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Medtronic PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 31,626,896 shares of MDT stock, worth $2.57 Billion. This represents 0.25% of its overall portfolio holdings.
Number of Shares
31,626,896
Previous 25,385,137
24.59%
Holding current value
$2.57 Billion
Previous $2.09 Billion
31.8%
% of portfolio
0.25%
Previous 0.22%
Shares
12 transactions
Others Institutions Holding MDT
# of Institutions
2,230Shares Held
1.05BCall Options Held
6.1MPut Options Held
7.84M-
Vanguard Group Inc Valley Forge, PA126MShares$10.3 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY114MShares$9.27 Billion0.23% of portfolio
-
State Street Corp Boston, MA60.1MShares$4.89 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA30.9MShares$2.51 Billion0.63% of portfolio
-
Morgan Stanley New York, NY27MShares$2.2 Billion0.19% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $108B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...